Acrosian

Acrosian is a biometrics-focused contract research organization (CRO) specializing in integrated delivery of four core functions: clinical data management, biostatistics, statistical programming, and medical writing. The company was founded by a team with two decades of experience building and scaling biometrics services, culminating in a successful exit to private equity.

Core Services:

• Clinical data management
• Biostatistics
• Statistical programming
• Medical writing

All functions are delivered through a unified quality system with single point of accountability, audit trails, and governance. The company differentiates through progressive AI augmentation built into every function from inception, designed to shift the ratio of senior expert judgment to repetitive labor while maintaining GxP validation rigor required for regulatory submissions.

Market Position: Acrosian positions itself as one of the industry's largest independent biometrics CROs, serving biotech companies developing programs across all phases of clinical development, clinical leaders coordinating biometrics delivery across multiple programs, and sponsor/CRO organizations building or validating AI capability in regulated environments.

Operations: Headquartered in Princeton, New Jersey, with operations spanning three continents including India and Europe.